On Tuesday, Insmed Inc (NASDAQ: INSM) opened higher 0.33% from the last session, before settling in for the closing price of $111.24. Price fluctuations for INSM have ranged from $60.40 to $111.28 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -13.12%. Company’s average yearly earnings per share was noted 6.20% at the time writing. With a float of $185.94 million, this company’s outstanding shares have now reached $189.95 million.
The extent of productivity of a business whose workforce counts for 1271 workers is very important to gauge. In terms of profitability, gross margin is 76.16%, operating margin of -230.21%, and the pretax margin is -264.87%.
Insmed Inc (INSM) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Insmed Inc is 2.11%, while institutional ownership is 108.88%. The most recent insider transaction that took place on Aug 04 ’25, was worth 749,801. Before that another transaction happened on Aug 04 ’25, when Company’s Officer proposed sale 8,715 for $109.47, making the entire transaction worth $954,031.
Insmed Inc (INSM) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 6.20% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 48.30% during the next five years compared to -13.12% drop over the previous five years of trading.
Insmed Inc (NASDAQ: INSM) Trading Performance Indicators
Check out the current performance indicators for Insmed Inc (INSM). In the past quarter, the stock posted a quick ratio of 5.44. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 55.64.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.95, a number that is poised to hit -1.29 in the next quarter and is forecasted to reach -3.66 in one year’s time.
Technical Analysis of Insmed Inc (INSM)
The latest stats from [Insmed Inc, INSM] show that its last 5-days average volume of 3.02 million was superior to 2.76 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 94.58%.
During the past 100 days, Insmed Inc’s (INSM) raw stochastic average was set at 97.17%, which indicates a significant increase from 87.10% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.84 in the past 14 days, which was lower than the 3.01 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $94.89, while its 200-day Moving Average is $78.52.
